Related Experiment Video
Updated: Jun 2, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Antiplatelet therapy in acute coronary syndromes: implications for nursing practice
Kathy Berra1, Barbara J Fletcher, Eileen Handberg
1Stanford Prevention Research Center, Stanford University School of Medicine, USA. kberra@stanford.edu
Insights
Acute coronary syndromes (ACSs) require advanced care beyond rest. Antiplatelet therapies are crucial for managing ACS, improving outcomes for myocardial infarction (MI) patients.
Area of Science:
- Cardiology
- Pharmacology
- Nursing
Background:
- Myocardial infarction (MI) care has advanced significantly, evolving from basic rest to complex interventions.
- The terminology has shifted from MI to acute coronary syndromes (ACSs), encompassing unstable angina, non-ST-elevation MI, and ST-elevation MI.
- ACS refers to clinical symptoms arising from acute myocardial ischemia.
Purpose of the Study:
- To review the pathophysiology of ACS.
- To elucidate the critical role of antiplatelet therapies in managing ACS.
- To discuss the impact of antiplatelet therapies on platelet function and the evolving role of nursing in patient care.
Main Methods:
- Literature review focusing on ACS pathophysiology.
- Analysis of antiplatelet therapy mechanisms and effects.
- Examination of nursing management strategies for ACS patients on antiplatelet agents.
Main Results:
- Antiplatelet therapies are vital in managing ACS by inhibiting platelet aggregation and activation.
- These therapies address both short- and long-term risks associated with atherosclerosis and ischemia.
- Nursing management has adapted to incorporate the complexities of antiplatelet therapies in ACS care.
Conclusions:
- Antiplatelet therapies are indispensable in the contemporary management of acute coronary syndromes.
- Understanding the pathophysiology and therapeutic mechanisms is key for effective patient care.
- Nurses play a pivotal role in managing patients with ACS receiving antiplatelet treatments.
Abstract:
The care of cardiovascular patients experiencing a myocardial infarction (MI) has evolved from simple bed rest and relief of pain to complex interventions and multiple medications that target both the short- and long-term risks associated with atherosclerosis and ischemia. Even the terminology has changed, from MI to acute coronary syndromes (ACSs). The term, acute coronary syndrome, refers to the clinical symptoms resulting from acute myocardial ischemia; it encompasses unstable angina, non-ST-elevation MI, and ST-elevation MI. Antiplatelet therapies are critically important in the management of patients with ACS. Antiplatelet therapies interfere with platelet aggregation and platelet activation both acutely and chronically and thus impact the development of acute MI. Thus, they are prescribed for millions of patients with ACS. As a result of this progress in treatment, nursing management of persons with ACS has also evolved. This article reviews the pathophysiology of ACS, the role of antiplatelet therapies, their effects on platelet adhesion, and the role of the nurse in caring for patients with ACS who are prescribed these important therapies.
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina V: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Angina IV: Management
